We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Guidelines Suggest Reduced Screening of Urine Cultures

By LabMedica International staff writers
Posted on 01 Apr 2019
Newly released diagnostic guidelines argue against antibiotic treatment of asymptomatic bacteriuria, which the guidelines consider to be an important opportunity for decreasing inappropriate antimicrobial use that promotes development of resistance by pathogens.

Asymptomatic bacteriuria (ASB) is the presence of one or more species of bacteria growing in the urine at specified quantitative counts (more than10^5 colony-forming units [CFU]/milliliter or more than 10^8 CFU/liter), irrespective of the presence of pyuria, in the absence of signs or symptoms attributable to urinary tract infection (UTI). More...
ASB is a common finding in some healthy female populations and in many women or men with abnormalities of the genitourinary tract that impair voiding.

In 2005, the Infectious Diseases Society of America (Arlington, VA, USA) published a guideline with recommendations for the management of ASB in adults. This guideline recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury.

The current guideline reviewed and updated the 2005 guideline, incorporating new evidence that had become available. The recommendations also considered populations not addressed in the 2005 guidelines, such as children and patients with solid organ transplants or neutropenia. The updated guideline also addressed the clinical presentation of symptomatic UTI in populations where there was a high prevalence of ASB, such as patients with spinal cord injury or older adults (over 65 years of age).

"Screening these patients is far too common and leads to the inappropriate prescribing of antibiotics, which some studies suggest may actually increase the risk of a UTI, as well as contribute to other serious infections such as Clostridioides difficile," said first author Dr. Lindsay E. Nicolle, chair of the committee that developed the guidelines and professor emeritus of health sciences at the University of Manitoba (Winnipeg, Canada). "Generally, physicians should not obtain urine cultures unless patients have symptoms consistent with an infection, such as burning during urination, frequent urination or abdominal pain or tenderness on the back near the lower ribs."

The latest guidelines were described in the March 21, 2019, online edition of the journal Clinical Infectious Diseases.

Related Links:
Infectious Diseases Society of America
University of Manitoba


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.